Total Funding
65
Total FundingSeries A raised
Growth Score in past quarter
pts
Heat Score 65 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Blue Note Therapeutics is a prescription digital therapeutics company that merges deep scientific and clinical expertise.
- Geoffrey Eich: CEO
About the Company
Blue Note Therapeutics is a prescription digital therapeutics company that merges deep scientific and clinical expertise. The company works with medical researchers and patient advocacy organizations to provide prescriptions to any patient using their mobile devices.
Blue Note Therapeutics was founded in 2018 and is based in San Francisco,
California.
